KNOSIS, the proprietary platform technology from Strategic Science & Technologies, LLC (SST), offers pharmaceutical and life science companies the ability to deliver pharmaceutical agents transdermally. This innovative technology provides a platform to create new topically applied drugs and reformulate existing orally and topically administered drugs for the treatment of a host of conditions. These include genital herpes, neuropathic pain, hives, acne, nail fungus, erectile dysfunction, Raynaud's disease, psoriasis, inflammation and pain, migraine headaches, female sexual dysfunction, and hair loss. In addition to providing its partners with the means to offer patients safer and more efficient treatment options, SST affords them the opportunity to tap the enormous commercial potential of transdermal drug delivery.